Trading Signals: CEMI Stock Price Prediction and Forecast (Wed. Nov. 26, 2003 - Wed. Jul. 21, 2021)(Chembio Diagnostics Inc)
| CEMI latest price $5.7300 (-4.5%) ($5.7300 - $6.0100) on Mon. Jun. 17, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.86% (three month average) | RSI | 31 | Latest Price | $5.7300(-4.5%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CEMI declines -1.6% a day on average for past five trading days. | Weekly Trend | CEMI declines -4.8% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Rotation from value to growth for small cap. | Correlated ETFs | Broad market will support CEMI advance at 0% a week (0% probability) ARKG(11%) IGOV(8%) VIXM(8%) XBI(8%) SHY(7%) | Factors Impacting CEMI price | CEMI will decline at least -1.43% in a week (0% probabilities). UNG(-11%) IFRA(-7%) XLP(-5%) VXX(-5%) XOP(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.43% (StdDev 2.86%) | Hourly BBV | 0 () | Intraday Trend | -3.9% | | | |
|
1 - 5 Day Possible Target | $-8.37(-246.07%) | Resistance Level | $6.63 | 5 Day Moving Average | $6.03(-4.98%) | 10 Day Moving Average | $6.31(-9.19%) | 20 Day Moving Average | $6.63(-13.57%) | To recent high | -27% | To recent low | 7.7% | Market Cap | $116m | | | | Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The firm expanding its product portfolio based upon the proprietary Dual Path Platform, which uses a small drop of blood from the fingertip to provide cost-effective diagnostic results in approximately 15 minutes. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Hauppauge, NY. |